Horizons 2006—RAPS Conference and Exhibition: Innovation to Regulation
Venue: Westin Horton Plaza Hotel
Location: San Diego, California, United States
Event Date/Time: Mar 29, 2006 | End Date/Time: Mar 31, 2006 |
Registration Date: Mar 27, 2006 | |
Early Registration Date: Mar 14, 2006 |
Description
Horizons 2006—RAPS Conference and Exhibition: Innovation to Regulation
29-31 March 2006
Westin Horton Plaza Hotel
910 Broadway Circle
San Diego, CA 92101
UNITED STATES
For Exhibitors
Reserve your tabletop
to exhibit today!
Horizons 2006—RAPS Conference & Exhibition: Innovation to Regulation (formerly West Coast Conference) is a multi-track educational and networking experience. This conference encompasses international perspectives across product lines and features multiple educational tracks, exhibits and opportunities for professionals in regulatory affairs, clinical trials and R&D to meet with peers.
The conference features five tracks:
clinical
early development
exposure to RA
senior RA
submission to market
Within each track, drug, device and biologics topics are highlighted, with a significant focus on international issues. Exclusive sessions also cater to the senior professional, and introductory workshops focus on those desiring exposure to regulatory affairs.
Just in!
Keynote Address: RAPS has secured D. Keith Grossman, President and CEO, Thoratec Corporation, and Bob O’Holla, Vice President, Regulatory Affairs, Johnson & Johnson Inc., to deliver this year’s keynote address, The Strategic Role of the Regulatory Professional.
FDA Briefings will include a CDRH briefing by Daniel G. Schultz, MD, Director, Center for Devices & Radiological Health, US Food & Drug Administration and a CDER briefing by Nancy D. Smith, PhD, Director, Office of Training & Communication, Center for Drug Evaluation & Research, US Food & Drug Administration.
Reasons to Attend
Participants from regulatory agencies, industry, academic and research institutions around the world are expected to attend this conference. It was developed to promote the advancement of continuing professional education to the RA professional who maintains experience in technical, compliance and management areas.
Whether new to regulatory affairs or well-versed in the intricacies of the profession, this conference was designed to further participants’ professional development. Senior professionals will also benefit from the interaction with FDA officials and the regulatory updates.
Learning Objectives
Participants will learn the latest in regulatory strategy and developments from regulatory experts around the world. Sessions will address the topical and relevant issues relating to drugs, biologics, medical devices and international affairs, with a particular focus on early lifecycle development.
Registration Rates Until March 14 After March 14
Member Registration $925 $1025
Nonmember Registration $1110 $1210